Adverse Events in Radiation/Biologic Combination Therapy for Older Non-Small-Cell Lung Cancer Patients

被引：0
|
作者：
Yerigeri, K. B. [1 ]
Zhang, J. [2 ]
Marrone, K. [2 ]
机构：
[1] Northeast Ohio Med Univ, Rootstown, OH USA
[2] Johns Hopkins, Sidney Kimmel Canc Ctr, Baltimore, MD USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2019年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
D37
引用
收藏
页码：S269 / S270
页数：2
相关论文
共 50 条
  • [21] Hycamtin in the therapy of non-small-cell lung cancer
    Gatzemeier, U
    ONKOLOGIE, 1998, 21 : 18 - 21
  • [22] Individualized therapy of non-small-cell lung cancer
    Rosell, R
    LUNG CANCER, 2004, 45 : S19 - S19
  • [23] Vaccine therapy in non-small-cell lung cancer
    Albright C.
    Garst J.
    Current Oncology Reports, 2007, 9 (4) : 241 - 246
  • [24] Maintenance therapy in non-small-cell lung cancer
    Stinchcombe, Thomas E.
    West, Howard L.
    LANCET, 2009, 374 (9699): : 1398 - 1400
  • [25] Targeted therapy in non-small-cell lung cancer
    Herbst, RS
    ONCOLOGY-NEW YORK, 2002, 16 (09): : 19 - 24
  • [26] Vaccination therapy for non-small-cell lung cancer
    Cuppens, Kristof
    Vansteenkiste, Johan
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (02) : 165 - 170
  • [27] Trimodality therapy for non-small-cell lung cancer
    Roberts, JR
    ONCOLOGY-NEW YORK, 1999, 13 (10): : 101 - 106
  • [28] Maintenance therapy for non-small-cell lung cancer
    Belani, Chandra P.
    Liao, Jason
    LANCET, 2010, 375 (9711): : 281 - 282
  • [29] What radiation dose is safe in patients with non-small-cell lung cancer?
    Larrier, Nicole A.
    Marks, Lawrence B.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (02): : 80 - 81
  • [30] Immune-related adverse events correlate with the clinical efficacy in advanced Non-Small-Cell Lung Cancer patients treated with PD-1 inhibitors combination therapy
    Xie, Xiaowan
    Li, Yuhao
    Lv, Qiaomei
    Wang, Wei
    Ding, Wenbo
    Li, Yuanyuan
    BMC CANCER, 2024, 24 (01)
12345